Clinical Trials

BreastEndocrineGastrointestinalGenitourinaryNET

2,076 enrolled

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT07354698 2026-01-21

MHI

Phase 4 Not yet recruiting

114 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT07272512 2025-12-19

ZSPAC-17

350 enrolled

Neuroendocrine Tumors

NCT06016855 2025-12-17

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

EndocrineGastrointestinalNETOther neoplasm

6 enrolled

Digestive System Neuroendocrine Tumor G1

NCT05631795 2025-12-03

ALPINIST

40 enrolled

Multiple Endocrine Neoplasia Type 1

NCT04081701 2025-11-21

DOMINO-START

200 enrolled

CNSEndocrine

Medulloblastoma, Meningioma, Paraganglioma, Pituitary Neoplasms, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory, Hemangioblastoma

NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Phase 4 Enrolling by invitation

800 enrolled

EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

30 enrolled

Pituitary Neoplasms

NCT05702944 2025-06-12

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

24 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

252 enrolled

Pituitary Neoplasms

NCT03289741 2025-05-09

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

51 enrolled 10 charts

Neuroendocrine Tumors

NCT02842749 2025-02-10

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

61 enrolled 9 charts

Pancreatic Neuroendocrine Tumors

NCT04524442 2025-01-24

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

42 enrolled 11 charts

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Neuroendocrine Tumors

NCT06679816 2025-01-14

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

882 enrolled

Pituitary Neoplasms

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

DermatologicEndocrineGenitourinaryNET

337 enrolled 8 charts

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT01379898 2024-09-19

PRESCRIPT

134 enrolled

Pheochromocytoma

NCT06576336 2024-08-28

3DAdrenal

350 enrolled

ACTH Syndrome, Ectopic, Adrenal Gland Neoplasms

NCT05701241 2024-06-14

SAUNA

270 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

Phase 4 Withdrawn

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

NCT05247476 2022-02-18

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

50 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Hypothyroidism

NCT02351700 2021-10-21

Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors

62 enrolled 14 charts

Pain, Pituitary Neoplasms

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

34 enrolled 8 charts

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

NCT04785222 2021-03-05

Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor

63 enrolled

Pituitary Neoplasms

NCT00681187 2019-11-22

SAPHE

26 enrolled 18 charts

Neuroendocrine Tumour With Carcinoid Symptoms

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

Neuroendocrine Tumors, Serotonin Syndrome

NCT01525550 2019-07-30

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

106 enrolled 26 charts

Adenoma, Carcinoma, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

28 enrolled

Neuroendocrine Tumors

NCT01595009 2018-11-29

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

246 enrolled 16 charts

Neuroendocrine Tumors

NCT03014687 2018-08-15

POET

116 enrolled

Pituitary Neoplasms

NCT03132259 2017-05-30

Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach

124 enrolled

Pituitary Neoplasms

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

40 enrolled

Pituitary Diseases, Pituitary Neoplasms

NCT01371643 2016-08-29

Surgical Debulking of Pituitary Adenomas

41 enrolled 11 charts

Pituitary Neoplasms

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

70 enrolled

EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT01554865 2015-07-29

Effects of Diet-induced Weight Loss in Obese Men

70 enrolled

EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT01642576 2015-07-29

Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men

90 enrolled

EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT01629225 2014-11-18

GRK4 Polymorphisms Blood Pressure Response to Candesartan

500 enrolled

Essential Hypertension, Multiple Endocrine Neoplasia Type 1

NCT01437696 2014-09-05

How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?

77 enrolled

Inflammation, Vitamin D Deficiency, Multiple Endocrine Neoplasia Type 1

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

13 enrolled

Multiple Endocrine Neoplasia Type 1

NCT01959711 2013-10-10

Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy

65 enrolled

Adrenal Gland Neoplasms, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

NCT00764114 2013-05-06

DTS

351 enrolled

Discitis, Multiple Endocrine Neoplasia Type 1

NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

72 enrolled 8 charts

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

NCT00493987 2010-05-13

5aR

184 enrolled

Multiple Endocrine Neoplasia Type 1

NCT00461149 2007-04-17

HDacro

50 enrolled